K. Kitazato

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

Frances E. Muldoon, Kenneth G. C. Smith, Eleanor F. Dewhurst, 2022, Nature.

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant

A. Kaneda, M. Seki, H. Nasser, 2022, Nature.

Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation

Y. Kawaoka, H. Nasser, M. Imai, 2021, Nature.

Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin.

H. Kato, H. Saito, K. Enjyoji, 1995, Blood.

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity

Eleanor, Joy, Josh, 2022 .

Interaction of a new depolymerized holothurian glycosaminoglycan with proteins in human plasma.

K. Kitazato, H. Nagase, K. Minamiguchi, 1996, Thrombosis research.